The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Properties and Opioid Inhibition of Mesolimbic Dopamine Neurons Vary according to Target Location
Open accessAbstract
The mesolimbic dopamine system, which mediates the rewarding properties of nearly all drugs of abuse, originates in the ventral tegmental area (VTA) and sends major projections to both the nucleus accumbens (NAc) and the basolateral amygdala (BLA). To address whether differences occur between neurons that project to these separate areas, retrograde microspheres were injected to either the BLA or the NAc of DBA/2J mice. Whole-cell recordings were made from labeled VTA dopamine neurons. We found that identified neurons that projected to the BLA and NAc originated within different quadrants of the VTA with neither group exhibiting large-amplitude h-currents. Neurons that projected to the NAc exhibited a greater outward current in response to the kappa-opioid agonist (5alpha,7alpha,8alpha)-(+)-N-methyl-N-[7-(pyrrolidinyl)-1-oxaspiro [4,5]dec-8-yl]-benzeneacetamide (U69593; 200 nM), whereas neurons that projected to the BLA exhibited greater inhibition to the mu/delta opioid agonist [Met5] enkephalin (ME; 3 microM). In addition, we found that the presynaptic inhibition of GABAergic transmission at both GABAA and GABAB receptors was differentially regulated by U69593 between the two groups. When dopamine IPSCs were examined, U69593 caused a greater inhibition in NAc- than BLA-projecting neurons. ME had no effect on either. Finally, the regulation of extracellular dopamine by dopamine uptake transporters was equal across the VTA. These results suggest that opioids differentially inhibit mesolimbic neurons depending on their target projections. Identifying the properties of projecting mesolimbic VTA dopamine neurons is crucial to understanding the action of drugs of abuse.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Species related quantitative differences in DA function between rats and mice may account for the differences in the results (42, 43).”
From Withdrawal from Chronic Nicotine Exposure Alters Dopamine Signaling Dynamics in the Nucleus Accumbens (2012) · cites this paper as [42]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Mouse Brain in Stereotaxic Coordinates
Paxinos, G. (2001) · Cited by 12,859
Drugs of abuse: anatomy, pharmacology and function of reward pathways
Koob, G. F. (1992) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(92)90060-j · Cited by 2,070
Swanson, L. W. (1982) · Brain Research Bulletin · doi:10.1016/0361-9230(82)90145-9 · Cited by 1,718 · cited 2×
“This contrasts with previous anatomical studies in the rat, which identified a substantial proportion of non-DAergic cells that send projections to these target areas (Swanson, 1982).”
ResultOpioids excite dopamine neurons by hyperpolarization of local interneurons
Johnson, S., & North, R. (1992) · The Journal of Neuroscience · doi:10.1523/jneurosci.12-02-00483.1992 · Cited by 1,637
Ikemoto, S., & Panksepp, J. (1999) · Brain Research Reviews · doi:10.1016/s0165-0173(99)00023-5 · Cited by 1,450
Mesocorticolimbic dopaminergic network: functional and regulatory roles
Moal, M. L., & Simon, H. (1991) · Physiological Reviews · doi:10.1152/physrev.1991.71.1.155 · Cited by 1,108
Wise, R. A. (1996) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(96)80079-1 · Cited by 1,072
Cellular and Synaptic Adaptations Mediating Opioid Dependence
Williams, J. T., Christie, M. J., & Manzoni, O. J. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.1.299 · Cited by 853
The neuropsychological basis of addictive behaviour
Everitt, B. J., Dickinson, A., & Robbins, T. W. (2001) · Brain Research Reviews · doi:10.1016/s0165-0173(01)00088-1 · Cited by 808
Addictive Drugs and Brain Stimulation Reward
Wise, R. A. (1996) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.19.030196.001535 · Cited by 792
Research works printed but not linked: 3
- (1993), J Pharmacol Exp Ther, 264, 489
- (2002), Sci STKE, 2002, PL2
- (1998), Neuroscience, 82, 59
Cited by
Sorted by citations
Items 101–200 of 340
Gremel, C. M., & Cunningham, C. L. (2008) · Neuropsychopharmacology · doi:10.1038/npp.2008.179 · Cited by 76
Modulation of 5-HT release by dynorphin mediates social deficits during opioid withdrawal
Pomrenze, M. B., Pinto, D. F. C., Neumann, P. A., Llorach, P., Tucciarone, J., Morishita, W., Eshel, N., Heifets, B. D., & Malenka, R. C. (2022) · Neuron · doi:10.1016/j.neuron.2022.09.024 · Cited by 79
Gehrke, B. J., Chefer, V. I., & Shippenberg, T. S. (2008) · Psychopharmacology · doi:10.1007/s00213-007-1067-6 · Cited by 75
Peri-Pubertal Emergence of UNC-5 Homologue Expression by Dopamine Neurons in Rodents
Manitt, C., Labelle‐Dumais, C., Eng, C., Grant, A., Mimee, A., Stroh, T., & Flores, C. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011463 · Cited by 72
Tan, H., Ahmad, T., Loureiro, M., Zunder, J. S., & Laviolette, S. R. (2014) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2014.00073 · Cited by 72
Branch, S. Y., Chen, C., Sharma, R., Lechleiter, J. D., Li, S., & Beckstead, M. J. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.1395-15.2016 · Cited by 69
Roles of Nucleus Accumbens CREB and Dynorphin in Dysregulation of MotivationPreprint
Muschamp, J. W., & Carlezon, W. A. (2013) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a012005 · Cited by 74
Wang, H., & Morales, M. (2008) · The Journal of Comparative Neurology · doi:10.1002/cne.21751 · Cited by 70
Branch, S. Y., & Beckstead, M. J. (2012) · Journal of Neurophysiology · doi:10.1152/jn.00094.2012 · Cited by 67
Tang, Y., Chen, Z., Tao, H., Li, C., Zhang, X., Tang, A., & Liu, Y. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.10.004 · Cited by 68
Polter, A. M., Bishop, R. A., Briand, L. A., Graziane, N., Pierce, R. C., & Kauer, J. A. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.04.019 · Cited by 67
Long-Term Depression of a Dopamine IPSC
Beckstead, M. J., & Williams, J. T. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.3251-06.2007 · Cited by 66
Ehrich, J. M., Phillips, P. E. M., & Chavkin, C. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.157 · Cited by 65
CRF Enhancement of GIRK Channel-Mediated Transmission in Dopamine Neurons
Beckstead, M. J., Gantz, S. C., Ford, C., Stenzel‐Poore, M. P., Phillips, P. E. M., Mark, G. P., & Williams, J. T. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2009.25 · Cited by 67
Keath, J. R., Iacoviello, M. P., Barrett, L. E., Mansvelder, H. D., & McGehee, D. S. (2007) · Journal of Neurophysiology · doi:10.1152/jn.00760.2007 · Cited by 66
Srinivasan, R., Henley, B. M., Henderson, B. J., Indersmitten, T., Cohen, B. N., Kim, C. H., McKinney, S. L., Deshpande, P., Xiao, C., & Lester, H. A. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.2126-15.2016 · Cited by 61
Thompson, J. L., & Borgland, S. L. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.10.026 · Cited by 65
Sharpe, A. L., Varela, E., Bettinger, L., & Beckstead, M. J. (2014) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyu073 · Cited by 65
Amygdala Circuits for Fear Memory: A Key Role for Dopamine Regulation
Lee, J. H., Lee, S. H., & Kim, J. (2016) · The Neuroscientist · doi:10.1177/1073858416679936 · Cited by 63
Krashia, P., Martini, A., Nobili, A., Aversa, D., D'Amelio, M., Berretta, N., Guatteo, E., & Mercuri, N. B. (2017) · European Journal of Neuroscience · doi:10.1111/ejn.13364 · Cited by 61
Melis, M., Diana, M., Enrico, P., Marinelli, M., & Brodie, M. S. (2009) · Alcohol · doi:10.1016/j.alcohol.2009.05.004 · Cited by 63
Thomas, C. S., Mohammadkhani, A., Rana, M., Qiao, M., Baimel, C., & Borgland, S. L. (2021) · Neuropsychopharmacology · doi:10.1038/s41386-021-01196-y · Cited by 68
The role of δ‐opioid receptors in learning and memory underlying the development of addiction
Klenowski, P. M., Morgan, M., & Bartlett, S. E. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12618 · Cited by 60
The Neurobiology of Opiate MotivationPreprint
Ting‐A‐Kee, R. A., & van der Kooy, D. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a012096 · Cited by 68
Deng, C., Li, K., Zhou, C., & Ye, J.-H. (2008) · Neuropsychopharmacology · doi:10.1038/npp.2008.143 · Cited by 59
Courtney, N. A., & Ford, C. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.0166-14.2014 · Cited by 63
Melis, M., Felice, M. D., Lecca, S., Fattore, L., & Pistis, M. (2013) · Frontiers in Integrative Neuroscience · doi:10.3389/fnint.2013.00093 · Cited by 61
Volatile Solvents as Drugs of Abuse: Focus on the Cortico-Mesolimbic Circuitry
Beckley, J. T., & Woodward, J. J. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.206 · Cited by 60
Kawahara, Y., Kaneko, F., Yamada, M., Kishikawa, Y., Kawahara, H., & Nishi, A. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.11.022 · Cited by 57
PPARα modulation of mesolimbic dopamine transmission rescues depression-related behaviors
Scheggi, S., Melis, M., De Felice, M., Aroni, S., Muntoni, A. L., Pelliccia, T., Gambarana, C., De Montis, M. G., & Pistis, M. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.07.024 · Cited by 56
GIRK Channels Modulate Opioid-Induced Motor Activity in a Cell Type- and Subunit-Dependent Manner
Kotecki, L., Hearing, M. C., McCall, N. M., de Velasco, E. M. F., Pravetoni, M., Arora, D. S., Victoria, N. C., Munoz, M. B., Xia, Z., Slesinger, P. A., et al. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.5051-14.2015 · Cited by 56
Chu, H., & Zhen, X. (2010) · Acta Pharmacologica Sinica · doi:10.1038/aps.2010.105 · Cited by 56
Neurochemical basis of conditioned partner preference in the female rat: I. Disruption by naloxone.
Coria‐Ávila, G. A., Solomon, C. E., Vargas, E. B., Lemme, I., Ryan, R., Ménard, S., Gavrila, A. M., & Pfaus, J. G. (2008) · Behavioral Neuroscience · doi:10.1037/0735-7044.122.2.385 · Cited by 55
Desensitized D2 autoreceptors are resistant to trafficking
Robinson, B. G., Bunzow, J. R., Grimm, J. B., Lavis, L. D., Dudman, J. T., Brown, J., Neve, K. A., & Williams, J. T. (2017) · Scientific Reports · doi:10.1038/s41598-017-04728-z · Cited by 55
Lintas, A., Chi, N., Lauzon, N. M., Bishop, S. F., Sun, N., Tan, H., & Laviolette, S. R. (2012) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2011.07943.x · Cited by 55
Distinct regulation of dopamine D2S and D2L autoreceptor signaling by calcium
Gantz, S. C., Robinson, B. G., Buck, D. C., Bunzow, J. R., Neve, R. L., Williams, J. T., & Neve, K. A. (2015) · eLife · doi:10.7554/elife.09358 · Cited by 55
CRF-R2 and the Heterosynaptic Regulation of VTA Glutamate during Reinstatement of Cocaine Seeking
Williams, C. L., Buchta, W. C., & Riegel, A. C. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.0911-13.2014 · Cited by 55
κ-Opioid Receptors in the Central Amygdala Regulate Ethanol Actions at Presynaptic GABAergic Sites
Kang-Park, M.-H., Kieffer, B. L., Roberts, A. J., Siggins, G. R., & Moore, S. D. (2013) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.202903 · Cited by 56
Insights to drug addiction derived from ultrastructural views of the mesocorticolimbic system
Morales, M., & Pickel, V. M. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2011.06299.x · Cited by 56
A subset of ventral tegmental area dopamine neurons responds to acute ethanol
Mrejeru, A., Martí‐Prats, L., Avegno, E. M., Harrison, N. L., & Sulzer, D. L. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2014.12.081 · Cited by 54
Ahmad, T., Lauzon, N. M., Jaeger, X. D., & Laviolette, S. R. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.1686-13.2013 · Cited by 53
Dopaminergic cellular and circuit contributions to kappa opioid receptor mediated aversion
Margolis, E. B., & Karkhanis, A. N. (2019) · Neurochemistry International · doi:10.1016/j.neuint.2019.104504 · Cited by 56
Visualizing endogenous opioid receptors in living neurons using ligand-directed chemistry
Arttamangkul, S., Plazek, A., Platt, E. J., Jin, H., Murray, T. F., Birdsong, W. T., Rice, K. C., Farrens, D., & Williams, J. T. (2019) · eLife · doi:10.7554/elife.49319 · Cited by 55
In Vivo Ethanol Experience Increases D2 Autoinhibition in the Ventral Tegmental Area
Perra, S., Clements, M. A., Bernier, B. E., & Morikawa, H. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2010.237 · Cited by 53
Ismail, N. I., Jayabalan, N., Mansor, S. M., Müller, C. P., & Mustapha, M. (2016) · Addiction Biology · doi:10.1111/adb.12385 · Cited by 52
Elmer, G. I., Pieper, J. O., Hamilton, L. R., & Wise, R. A. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1732-z · Cited by 51
Stelly, C. E., Pomrenze, M. B., Cook, J. B., & Morikawa, H. (2016) · eLife · doi:10.7554/elife.15448 · Cited by 55
Laurent, R. S., Damonte, V. M., Tsuda, A. C., & Kauer, J. A. (2020) · Neuron · doi:10.1016/j.neuron.2020.02.029 · Cited by 51
Polter, A. M., Barcomb, K., Chen, R. W., Dingess, P. M., Graziane, N., Brown, T. E., & Kauer, J. A. (2017) · eLife · doi:10.7554/elife.23785 · Cited by 53
Loss of Morphine Reward and Dependence in Mice Lacking G Protein–Coupled Receptor Kinase 5
Glück, L., Loktev, A., Moulédous, L., Mollereau, C., Law, P., & Schulz, S. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.01.021 · Cited by 49
Hikima, T., Lee, C. R., Witkovsky, P., Chesler, J., Ichtchenko, K., & Rice, M. E. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.108951 · Cited by 49
Opiates and Plasticity in the Ventral Tegmental Area
Langlois, L. D., & Nugent, F. S. (2017) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00281 · Cited by 49
Dynorphin and its role in alcohol use disorder
Karkhanis, A. N., & Al-Hasani, R. (2020) · Brain Research · doi:10.1016/j.brainres.2020.146742 · Cited by 47
Nicotine and alcohol: the role of midbrain dopaminergic neurons in drug reinforcement
Morel, C., Montgomery, S. E., & Han, M. (2018) · European Journal of Neuroscience · doi:10.1111/ejn.14160 · Cited by 50
Ahn, K.-C., Bernier, B. E., Harnett, M. T., & Morikawa, H. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.4453-09.2010 · Cited by 44
A mesocorticolimbic signature of pleasure in the human brain
Kragel, P. A., Treadway, M. T., Admon, R., Pizzagalli, D. A., & Hahn, E. C. (2023) · Nature Human Behaviour · doi:10.1038/s41562-023-01639-0 · Cited by 44
Crucial Role of Acetaldehyde in Alcohol Activation of the Mesolimbic Dopamine System
Diana, M., Peana, A. T., Sirca, D., Lintas, A., Melis, M., & Enrico, P. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1432.009 · Cited by 43
Courtney, N. A., Mamaligas, A. A., & Ford, C. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.2745-12.2012 · Cited by 40
Cao, L., Fu, M., Kumar, S., & Kumar, A. (2016) · Cell Death and Disease · doi:10.1038/cddis.2016.317 · Cited by 43
Beckley, J. T., Evins, C. E., Fedarovich, H., Gilstrap, M. J., & Woodward, J. J. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.3729-12.2013 · Cited by 42
Horváth, M., Kovács, G. G., Kövari, V., Majtényi, K., Hurd, Y. L., & Keller, É. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.2398-07.2007 · Cited by 42
Depression of Serotonin Synaptic Transmission by the Dopamine Precursor L-DOPA
Gantz, S. C., Levitt, E. S., Llamosas, N., Neve, K. A., & Williams, J. T. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.07.005 · Cited by 40
Piray, P., Keramati, M., Dezfouli, A., Lucas, C., & Mokri, A. (2010) · Neural Computation · doi:10.1162/neco_a_00009 · Cited by 40
Prolonged, Severe Intrathecal Baclofen Withdrawal Syndrome: A Case Report
Hansen, C. R., Gooch, J. L., & Such-Neibar, T. (2007) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/j.apmr.2007.07.021 · Cited by 40
Enhanced Nicotinic Receptor Function and Drug Abuse Vulnerability
Fagen, Z. M., Mitchum, R. D., Vezina, P., & McGehee, D. S. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.2017-06.2007 · Cited by 41
A-Kinase Anchoring Protein–Calcineurin Signaling in Long-Term Depression of GABAergic Synapses
Dacher, M., Gouty, S., Dash, S., Cox, B. M., & Nugent, F. S. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.2037-12.2013 · Cited by 38
The amygdala as a target for behavior surgery
Langevin, J. (2012) · Surgical Neurology International · doi:10.4103/2152-7806.91609 · Cited by 43
Bupropion inhibits the cellular effects of nicotine in the ventral tegmental area
Mansvelder, H. D., Fagen, Z. M., Chang, B., Mitchum, R. D., & McGehee, D. S. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.07.034 · Cited by 40
Margolis, E. B., Fujita, W., Devi, L. A., & Fields, H. L. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.06.019 · Cited by 39
Cocaine inhibition of nicotinic acetylcholine receptors influences dopamine release
Acevedo-Rodriguez, A., Zhang, L., Zhou, F., Gong, S., Gu, H. H., Biasi, M. D., Zhou, F.-M., & Dani, J. A. (2014) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2014.00019 · Cited by 37
Dobbs, L. K., Lemos, J. C., & Alvarez, V. A. (2016) · Genes Brain & Behavior · doi:10.1111/gbb.12361 · Cited by 40
Placzek, A. N., Prisco, G. V. D., Khatiwada, S., Sgritta, M., Huang, W., Krnjević, K., Kaufman, R. J., Dani, J. A., Walter, P., & Costa‐Mattioli, M. (2016) · eLife · doi:10.7554/elife.17517 · Cited by 35
Convergent Neuronal Plasticity and Metaplasticity Mechanisms of Stress, Nicotine, and Alcohol
Ostroumov, A., & Dani, J. A. (2017) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010617-052735 · Cited by 36
Lyons, D. C. A., Jaeger, X. D., Rosen, L. G., Ahmad, T., Lauzon, N. M., Zunder, J. S., Coolen, L. M., Rushlow, W. J., & Laviolette, S. R. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.1226-13.2013 · Cited by 36
Melis, M., Pillolla, G., Perra, S., Colombo, G., Muntoni, A. L., & Pistis, M. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1309-2 · Cited by 36
Guan, Y., Xiao, C., Krnjević, K., Xie, G., Zuo, W., & Ye, J.-H. (2011) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.187963 · Cited by 35
Rosen, L. G., Sun, N., Rushlow, W. J., & Laviolette, S. R. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00399 · Cited by 34
McCall, N. M., de Velasco, E. M. F., & Wickman, K. (2019) · Journal of Neuroscience · doi:10.1523/jneurosci.3101-18.2019 · Cited by 34
A midbrain dynorphin circuit promotes threat generalization
Fellinger, L., Jo, Y. S., Hunker, A. C., Soden, M. E., Elum, J. E., Juarez, B., & Zweifel, L. S. (2021) · Current Biology · doi:10.1016/j.cub.2021.07.047 · Cited by 34
Xiao, C., Zhou, C., Li, K., Davies, D. L., & Ye, J. H. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.139766 · Cited by 34
Vena, A. A., Zandy, S. L., Cofresí, R. U., & Gonzales, R. A. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107573 · Cited by 33
Early life stress dysregulates kappa opioid receptor signaling within the lateral habenula
Simmons, S. C., Shepard, R. D., Gouty, S., Langlois, L. D., Flerlage, W. J., Cox, B. M., & Nugent, F. S. (2020) · Neurobiology of Stress · doi:10.1016/j.ynstr.2020.100267 · Cited by 32
Trifilieff, P., & Martínez, D. (2013) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2013.00044 · Cited by 35
Sun, N., & Laviolette, S. R. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2665-5 · Cited by 31
Functionality versus dimensionality in psychological taxonomies, and a puzzle of emotional valence
Trofimova, I. N. (2018) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2017.0167 · Cited by 34
Electrophysiological Characteristics of Dopamine Neurons: A 35-Year Update
Shi, W. (2009) · Springer eBooks · doi:10.1007/978-3-211-92660-4_8 · Cited by 31
Crosstalk Between Kappa Opioid and Dopamine Systems in Compulsive Behaviors
Escobar, A. P., Casanova, J. P., Andrés, M. E., & Fuentealba, J. A. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00057 · Cited by 32
Neve, K. A., Ford, C., Buck, D. C., Grandy, D. K., Neve, R. L., & Phillips, T. J. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.06.035 · Cited by 31
Coutens, B., & Ingram, S. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.109408 · Cited by 30
Wills, K. L., Vemuri, K., Kalmar, A., Lee, A., Limebeer, C. L., Makriyannis, A., & Parker, L. A. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3575-5 · Cited by 29
Hazim, A. I., Mustapha, M., & Mansor, S. M. (2011) · Journal of Medicinal Plants Research · doi:10.5897/jmpr.9001209 · Cited by 29
Alcohol effects on synaptic transmission in periaqueductal gray dopamine neurons
Li, C., McCall, N. M., López, A. J., & Kash, T. L. (2013) · Alcohol · doi:10.1016/j.alcohol.2013.02.002 · Cited by 29
Navarro, G., Rea, W. P., Quiroz, C., Moreno, E., Gomez, D. M., Wenthur, C. J., Casadó, V., Leggio, L., Hearing, M. C., & Ferré, S. (2021) · Journal of Neuroscience · doi:10.1523/jneurosci.1151-21.2021 · Cited by 28
Psychiatric neural networks and neuropharmacology: Selected advances and novel implications
Ghanemi, A. (2013) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2013.01.008 · Cited by 27
Li, Y., Yu, L., Zhao, L., Zeng, F., & Liu, Q.-S. (2017) · Scientific Reports · doi:10.1038/s41598-017-16034-9 · Cited by 26
Placzek, A. N., Molfese, D. L., Khatiwada, S., Prisco, G. V. D., Huang, W., Sidrauski, C., Krnjević, K., Amos, C. L., Ray, R. S., Dani, J. A., et al. (2016) · eLife · doi:10.7554/elife.12056 · Cited by 27
Tovar-Díaz, J., Pomrenze, M. B., Pahlavan, B., Kan, R., Drew, M. R., & Morikawa, H. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.02.039 · Cited by 29
Namba, H., Zheng, Y., Abe, Y., & Nawa, H. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.10.057 · Cited by 27
Simmons, S. C., Wheeler, K., & Mazei‐Robison, M. S. (2019) · Molecular Brain · doi:10.1186/s13041-019-0435-6 · Cited by 28
Lockie, S. H., Czyzyk, T. A., Chaudhary, N., Pérez–Tilve, D., Woods, S. C., Oldfield, B. J., Statnick, M. A., & Tschöp, M. H. (2011) · Endocrinology · doi:10.1210/en.2011-1220 · Cited by 24
Metadata
- Authors
- Ford, C. P., Mark, G. P., & Williams, J. T.
- Affiliations
- Oregon Health & Science University (US)
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2006-03-08
- Volume
- 26
- Issue
- 10
- Pages
- 2788-2797
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- PMC
- PMC3623681
- OpenAlex
- W2012111567
- Cited by
- 339
- References
- 52
- Citations by year
- 2026: 12 · 2025: 9 · 2024: 7 · 2023: 14 · 2022: 14 · 2021: 8 · 2020: 14 · 2019: 14 · 2018: 10 · 2017: 24 · 2016: 22 · 2015: 26 · 2014: 25 · 2013: 28 · 2012: 21
- FWCI
- 7.20
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Neuroscience (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- Funders
- Life Sciences Research Foundation
- Fondation pour la Recherche Médicale
- National Institutes of Health
- National Institute on Drug Abuse (DA04523, DA 014639, R01DA008163, DA-08163, R01DA014639, R01DA004523)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- mesolimbic dopamine system, ventral tegmental area, nucleus accumbens, basolateral amygdala, opioid inhibition, kappa opioid receptor, [Met5]enkephalin, presynaptic inhibition, GABAA receptor, GABAB receptors, retrograde tracing, drug reward
- MeSH terms
- Amygdala, Analgesics, Animals, Bicuculline, Biotin, Cell Count, Dopamine, Dose-Response Relationship, Radiation, Drug Interactions, Electric Stimulation, Female, Immunohistochemistry, Limbic System, Male, Membrane Potentials, Mice, Inbred DBA, Microinjections, Molecular Sequence Data, Naloxone, Narcotic Antagonists, Narcotics, Neural Inhibition, Neural Pathways, Synaptic Transmission, Neurons, Nucleus Accumbens, Reaction Time, Serotonin, Tyrosine 3-Monooxygenase, Serotonin Receptor Agonists, Ventral Tegmental Area, Patch-Clamp Techniques, GABA Antagonists, Mice, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
